Brief: Xeris Biopharma Q3 Net Income USD -12.189 Million
09/11/2023 12:00
Nov 09 (Reuters) - Xeris Biopharma Q3 basic EPS USD -0.09. * Q3 product revenue USD 41.697 million vs. IBES estimate USD 41.1 million * Q3 operating income USD -4.913 million
Recent news on Xeris Biopharma Holdings
See all newsBrief: Xeris Biopharma Files Patent Infringement Lawsuits In US District Court - SEC Filing
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
Lundbeck expresses interest in buying Xeris, Bloomberg News reports (updated)
Xeris Biopharma rises on report of Lundbeck takeover interest